Correlation Between Visa and Pharma Equity
Can any of the company-specific risk be diversified away by investing in both Visa and Pharma Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Pharma Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Pharma Equity Group, you can compare the effects of market volatilities on Visa and Pharma Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Pharma Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Pharma Equity.
Diversification Opportunities for Visa and Pharma Equity
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Visa and Pharma is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Pharma Equity Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Equity Group and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Pharma Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Equity Group has no effect on the direction of Visa i.e., Visa and Pharma Equity go up and down completely randomly.
Pair Corralation between Visa and Pharma Equity
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.23 times more return on investment than Pharma Equity. However, Visa Class A is 4.3 times less risky than Pharma Equity. It trades about 0.35 of its potential returns per unit of risk. Pharma Equity Group is currently generating about -0.14 per unit of risk. If you would invest 28,929 in Visa Class A on September 1, 2024 and sell it today you would earn a total of 2,579 from holding Visa Class A or generate 8.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 91.3% |
| Values | Daily Returns |
Visa Class A vs. Pharma Equity Group
Performance |
| Timeline |
| Visa Class A |
| Pharma Equity Group |
Visa and Pharma Equity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Pharma Equity
The main advantage of trading using opposite Visa and Pharma Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Pharma Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Equity will offset losses from the drop in Pharma Equity's long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| Pharma Equity vs. BankIn Bredygt Klimaakt | Pharma Equity vs. Nordinvestments AS | Pharma Equity vs. Kreditbanken AS | Pharma Equity vs. Lollands Bank |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |